PetVivo Holdings Inc PETV

Morningstar Rating
$0.69 −0.01 (0.92%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PETV is trading within a range we consider fairly valued.
Price
$0.69
Fair Value
LOCK|Tlrmvf%
Uncertainty
LOCK|@! r?lh!
1-Star Price
LOCK|dH$kKF
5-Star Price
LOCK|ppWX%J
Economic Moat
LOCK|!v
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.69
Day Range
$0.69–0.69
52-Week Range
$0.59–1.69
Bid/Ask
$0.69 / $0.73
Shares Outstanding
37.95M
Market Cap
$25.06M
Volume/Avg
2,100 / 14,384

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
19.39
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
22

Valuation

Metric
PETV
Price/Earnings (Normalized)
—
Price/Book Value
19.12
Price/Sales
19.39
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
PETV
Quick Ratio
0.16
Current Ratio
0.72
Interest Coverage
−9.30
Quick Ratio
PETV

Profitability

Metric
PETV
Return on Assets (Normalized)
−144.24%
Return on Equity (Normalized)
−221.63%
Return on Invested Capital (Normalized)
−160.90%
Return on Assets
PETV

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|X#xX<hLOCK|vyw#Z$177B
Medtronic PLC
MDT
LOCK|%#z?c@NLOCK|$%Ys$124B
Stryker Corp
SYK
LOCK|Wf&%$Y>LOCK|#QF$118B
Boston Scientific Corp
BSX
LOCK|<#f@!xLOCK|?phx$67B
Edwards Lifesciences Corp
EW
LOCK|$msXv&>VLOCK|FmB@K$52B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|vZ%y>jLOCK|T#Q$32B
DexCom Inc
DXCM
LOCK|?$g$%ySXLOCK|%!>pK$30B
Koninklijke Philips NV ADR
PHG
LOCK|&YLOCK|@Vn$26B
Steris PLC
STE
LOCK|ww&@>#JLOCK|wkzc%$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|@<>$^rb!LOCK|Rr$19B

Sponsor Center